LexDanaLexDanabeta
Inventor

Francoise Bono

Inventor
Toulouse, FR

Overview

19→
Patents
2007–2015
Patent span
Human necessities
Primary field (CPC A)

Patents· 19 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations38%
C07DHeterocyclic compounds36%
A61KPreparations for medical, dental or toiletry purposes22%
C08GMacromolecular compounds obtained otherwise than by reactions only involving unsaturated carbon-to-carbon bonds4%
PatentTitleYear
9,120,819'FGF-receptor agonist dimeric compounds'20158,957,211'(Heterocycle/condensed piperidine)-(piperazinyl)-1-alkanone or (heterocycle/condensed pyrrolidine)-(piperazinyl)-1-alkanone derivatives and use thereof as p75 inhibitors'20158,906,924'(heterocycle/tetrahydropyridine)-(piperazinyl)-1-alcanone and (heterocycle/dihydropyrrolidine)-(piperazinyl)-1-alcanone derivatives, and use thereof as p75 inhibitors'20148,633,216'Imidazo[1,5-a]pyridine derivatives, method for preparing same and pharmaceutical compositions containing same'20148,586,602'Derivatives of 7 alkynyl-1,8 naphthyridones, preparation method thereof and use of same in therapeutics'20138,580,790'(Heterocycle/condensed piperidine)-(piperazinyl)-1-alkanone or (heterocycle/condensed pyrrolidine)-(piperazinyl)-1-alkanone derivatives and use thereof as p75 inhibitors'20138,519,143'Derivatives of (bridged piperazinyl)-1-alkanone and use thereof as p75 inhibitors'20138,518,947'(Heterocycle/tetrahydropyridine)-(piperazinyl)-1-alcanone and (heterocycle/dihydropyrrolidine)-(piperazinyl)-1-alcanone derivatives, and use thereof as p75 inhibitors'20138,470,847'Derivatives of 7-alkynyl-1,8-naphthyridones, preparation method thereof and use of same in therapeutics'20138,263,614'Derivatives of 7-alkynyl-1,8-naphthyridones, preparation method thereof and use of same in therapeutics'20128,247,404'Derivatives of 2-oxoalkyl-1-piperazin-2-one, preparation method thereof and therapeutic use of same'20128,193,190'Derivatives of (bridged piperazinyl)-1-alkanone and use thereof as p75 inhibitors'20128,034,828'Use of FGF inhibiting substituted 1,2,3 indolizine derivatives in the preparation of medicaments which can be used to treat diseases linked to pathological choroidal angiogenesis'20118,008,321'Imidazo[1,5-a] pyridine derivatives, method for preparing same and pharmaceutical compositions containing same'20117,803,811'1,2,3-substituted indolizine derivatives, inhibitors of FGFs, method for preparing them and pharmaceutical compositions containing them'20107,553,845'Substituted indolizine 1,2,3,6,7,8 derivatives, FGFs inhibitors, a method for the preparation thereof and pharmaceutical compositions containing said derivatives'20097,468,368'Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof'20087,442,708'1,2,3-substituted indolizine derivatives, inhibitors of fgfs, method for making same and pharmaceutical compositions containing same'20087,294,628'Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof'2007

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2007–2012Patents assigned to SANOFI AVENTIS (9)· patent assignee history
2007–2015Based in Toulouse, FR· patent location history
2012–2015Patents assigned to BONO FRANCOISE (10)· patent assignee history
2012–2015Patents assigned to SANOFI SA (10)· patent assignee history
2012–2013Patents assigned to BARONI MARCO (5)· patent assignee history
2012–2013Patents assigned to DELBARY-GOSSART SANDRINE (5)· patent assignee history
2012–2015Based in Paris, FR· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
BONO FRANCOISEself102012–2015
SANOFI SA102012–2015
SANOFI AVENTIS92007–2012
BARONI MARCO52012–2013
DELBARY-GOSSART SANDRINE52012–2013
Locations
LocationPatentsSpan
Toulouse, FR142007–2015
Paris, FR52012–2015